Valuation : AtriCure, Inc.

Market Cap 250.62Cr 215.13Cr 201.41Cr 184.43Cr 347.42Cr 24TCr 348.41Cr 2.38TCr 932.32Cr 12TCr 940.95Cr 920.62Cr 40TCr P/E 2026 *
467x
P/E 2027 * 118x
Enterprise Value 235.41Cr 202.07Cr 189.18Cr 173.23Cr 326.34Cr 22TCr 327.26Cr 2.24TCr 875.74Cr 11TCr 883.84Cr 864.74Cr 38TCr EV / Sales 2026 *
3.88x
EV / Sales 2027 * 3.35x
Free-Float
96.19%
Yield 2026 *
-
Yield 2027 * -
1 day+2.28%
1 week+3.75%
Current month+30.48%
1 month+31.84%
3 months+79.49%
6 months+57.61%
Current year+24.54%
1 week 47.06
Extreme 47.06
49.88
1 month 37.44
Extreme 37.44
49.88
Current year 25.36
Extreme 25.36
49.88
1 year 25.36
Extreme 25.36
49.88
3 years 18.94
Extreme 18.94
49.88
5 years 18.94
Extreme 18.94
89.18
10 years 14.52
Extreme 14.52
89.18
Manager TitleAgeSince
Chief Executive Officer 55 02/11/2012
Director of Finance/CFO 48 01/07/2014
Chief Tech/Sci/R&D Officer 59 18/07/2017
Director TitleAgeSince
Director/Board Member 55 02/11/2012
Director/Board Member 64 11/03/2013
Director/Board Member 75 10/11/2016
Date Insider Type Main position Quantity % Market Cap.
24/08/26 Sell

General Counsel

-9,370 0.0184%
05/08/26 Sell

Director

-3,500 0.0069%
05/08/26 Sell

Director

-3,564 0.0070%
Change 5-day change 1-year change 3-year change Capi.($)
+2.28%+3.75%+32.09%+7.11% 245.02Cr
-2.20%-2.23%-15.11%+7.08% 20TCr
-2.23%-2.52%-2.26%+9.47% 12TCr
-2.00%+2.08%+10.56%+78.98% 6.26TCr
-0.14%-3.88%+26.84%+53.26% 5.24TCr
-1.09%+0.27%-3.72%-32.81% 5.18TCr
+0.37%-1.03%+16.90%-11.38% 3.36TCr
+0.20%+6.35% - - 3.03TCr
-1.09%-2.17%+40.70%-12.10% 2.46TCr
+0.29%+3.86%-2.97%+19.56% 2.38TCr
Average -0.56%+0.81%+11.45%+13.24% 5.97TCr
Weighted average by Cap. -1.48%-0.74%+0.36%+14.74%

Financials

2026 *2027 *
Net sales 61Cr 52Cr 49Cr 45Cr 84Cr 5.79TCr 84Cr 576.91Cr 225.52Cr 2.92TCr 227.61Cr 222.69Cr 9.66TCr 68Cr 58Cr 55Cr 50Cr 94Cr 6.49TCr 94Cr 646.76Cr 252.83Cr 3.27TCr 255.17Cr 249.66Cr 11TCr
Net income 71.12L 61.05L 57.16L 52.34L 98.6L 68Cr 98.88L 6.77Cr 2.65Cr 34Cr 2.67Cr 2.61Cr 113.31Cr 2.08Cr 1.78Cr 1.67Cr 1.53Cr 2.88Cr 198.43Cr 2.89Cr 20Cr 7.73Cr 100.01Cr 7.8Cr 7.63Cr 330.99Cr
Net Debt -15Cr -13Cr -12Cr -11Cr -21Cr -1.45TCr -21Cr -144.76Cr -57Cr -732.2Cr -57Cr -56Cr -2.42TCr -23Cr -19Cr -18Cr -17Cr -31Cr -2.16TCr -31Cr -215.36Cr -84Cr -1.09TCr -85Cr -83Cr -3.61TCr
Logo AtriCure, Inc.
AtriCure, Inc. provides technologies for the treatment for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management. The Company's cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Its pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures. The Company's products for open and minimally invasive ablation include Isolator Synergy Clamps and Multifunctional Pens and Linear Ablation Devices. Its products for open ablation include cryoICE Cryoablation System. Its products for minimally invasive ablation include EPi-Sense Guided Coagulation System with VisiTrax Technology. Its appendage management products include AtriClip System. The Isolator Synergy Ablation System clamps are single-use disposable radio frequency (RF) products with jaws that close in a parallel fashion.
Employees
1,350
Date Price Change Volume
27/26/27 $49.27 +2.28% 7,66,478
26/26/26 $48.17 -1.05% 8,59,694
25/26/25 $48.68 -1.22% 9,66,672
24/26/24 $49.28 +0.61% 4,38,902
21/26/21 $48.98 +3.14% 4,21,181
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
49.27USD
Average target price
49.56USD
Spread / Average Target
+0.58%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ATRC Stock